Oxford Drug Design Limited

Funded awards at Oxford Drug Design Limited.

Funded awards

Published Funding

£4.2M

Average published award

£706K

Active funded awards

Amounts are published for 6 of 7 funded awards. Data as of 16 July 2026.

The biggest topic here is Infection & Immunity — 4 grants (57%). The busiest year was 2019, with 2 grants.

Funded Awards by Year

View data table


Novel tRNA synthetase inhibitors to treat drug resistant Gram-negative infections	Oxford Drug Design Limited	InnovateUK	£2.0M	2019	Completed
Dual-target tRNA synthetase inhibitors for the treatment of drug-resistant bacterial infections	Oxford Drug Design Limited	InnovateUK	£922K	2017	Completed
Novel small molecule and TCM approaches to support pig production, minimizing generation of resistance to human antibiotics	Oxford Drug Design Limited	InnovateUK	£731K	2019	Completed
A Novel Veterinary-only Antibiotic for the Treatment of S. suis Infections in Pigs	Oxford Drug Design Limited	UKRI	£392K	2024	Completed
Continuity Grant support for Oxford Drug Design Uk-China AMR project	Oxford Drug Design Limited	InnovateUK	£142K	2020	Completed
The development of novel antibiotics for drug resistant infections	Oxford Drug Design Limited	InnovateUK	£68K	2021	Completed
Combatting Antimicrobial Resistance Training Network	Oxford Drug Design Limited	EC	Not disclosed	2018	Completed